Live
- Karnataka Chief Minister Siddaramaiah Offers Condolences To Grieving Father Of Stabbing Victim
- BJP winning 35 seats in Bengal will guarantee freedom from illegal infiltration: Amit Shah
- Assault Incident In Karnataka Sparks Controversy Amidst Rising Tensions
- Only 6 minutes’ role in 222 days at Parliament
- CM Kejriwal, K Kavitha’s judicial custody extended in money laundering case till May 7
- Women BJD leaders Raseswari, Simarani quit party
- BJP overlooked TG projects in Parliament: Manne Srinivas
- Nothing Phone 3 with Model Number A015 May Launch in July
- Allari Naresh’s ‘Aa Okkati Adakku’ trailer promises hilarious family entertainment
- Hanuman Jayanthi special: Prasanth Varma unveils new poster of ‘Jai Hanuman’
Sun Pharma drops 7.5 per cent on Sebi report
Highlights
Shares of Sun Pharmaceutical Monday dived 75 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters The companys shares fell 752 per cent to end at Rs 45530 apiece on the BSE
New Delhi: Shares of Sun Pharmaceutical Monday dived 7.5 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters. The company's shares fell 7.52 per cent to end at Rs 455.30 apiece on the BSE.
During the day, the stock declined 10.22 per cent to Rs 441.95. On the NSE, the scrip of the company slumped by 7.53 per cent to close at Rs 455.50. In terms of volume, over 48 lakh shares were traded on the BSE, while over 6 crore units changed hands on the NSE.
Next Story
ADVERTISEMENT
